Publikationen

Siemens, W.; Von Elm, E.; Binder, H.; Böhringer, D.; Eisele-Metzger, A.; Gartlehner, G.; Hanegraaf, P.; Metzendorf, M.I.; Mosselman, J.J.; Nowak, A.; Qureshi, R.; Thomas, J.; Waffenschmidt, S.; Labonte, V.; Meerpohl, J.J. (2025). Opportunities, challenges and risks of using artificial intelligence for evidence synthesis. BMJ Evidence-Based Medicine, Online ahead of print: doi: 10.1136/bmjebm-2024-113320.

Griebler, U.; Kien, C.; Klerings, I.; Lutz, B.; Krczal, E.; Ledinger, D.; Mair, I.; Emprechtinger, R.; Keser Aschenberger, F.; Kerschner, B. (2024). Info without Side Effects (iWISE): Development of a validated lay checklist for assessing online health information - a mixed-methods study. JMIR Preprints, preprint: 10.2196/preprints.69529

Sharifan, A. (2024). What are the effects of vitamin D in the management of chronic obstructive pulmonary disease (COPD)? Cochrane Clinical Answers, https://doi.org//10.1002/cca.4506: https://doi.org/10.1002/cca.4506

Sharifan, A. (2024). Adherence to Reporting Guidelines: Recommendation or Requirement? American Journal of Therapeutics, 10.1097: 10.1097/MJT.0000000000001822

Gartlehner, G.; Kahwati, L.; Nussbaumer-Streit, B.; Crotty, K.; Hilscher, R.; Kugley, S.; Viswanathan, M.; Thomas, I.; Konte, A.; Booth, G.; Chew, R. (2024). From promise to practice: challenges and pitfalls in the evaluation of large language models for data extraction in evidence synthesis. BMJ Evidence-Based Medicine, Online First: doi: 10.1136/bmjebm-2024-113199

Wagner, G.; Gartlehner, G.; Thaler, K.; Ledinger, D.; Feyertag, J.; Klerings, I.; Saif-Ur-Rahman, K.M.; Devane, D.; Olsson, K.; Adel Ali, K.; Vygen-Bonnet, S.; Salo, H.; Zavadska, D.; Grgiic Vitek, M.; Oona, M.; Cunney, R.; Tuerlinckx, D.; Kristensen Lomholt, F.; Sommer, I. (2024). Immunogenicity and safety of the 15- valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. NPJ Vaccines, 9(1):257: 10.1038/s41541-024-01048-y.

GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, 404: 2341-70

Emprechtinger, R.; Schwarzer, G.; Schreder, G.; Tolch, U.; Gartlehner, G. (2024). Assessing the Effectiveness of metaHelper: A Randomized Controlled Trial of a Web Application for Statistical Transformations in Meta-Analysis. Journal of Clinical Epidemiology, online ahead of print: https:// doi.org/10.1016/j.jclinepi.2024.111640

King, V.J.; Nussbaumer-Streit, B.; Shaw, E.; Devane, D.; Kahwati, L.; Viswanathan, M.; Gartlehner, G.; Cochrane Rapid Reviews Methods Group (2024). Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews. BMJ Evidence-Based Medicine, 29: 419-422

GBD 2021 Diarrhoeal Diseases Collaborators; Sharifan, A. (2024). Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis, Published Online: https://doi.org/10.1016/ S1473-3099(24)00691-1

GBD 2021 HIV Collaborators; Sharifan, A. (2024). Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV, 11, Issue 12: e807-e822

Kontor, E.K.; Wellan, C.; Mohammad Maaz, H.; Garba Muhammad, D.; Al-Qiami, A.; Sharifan, A.; Kumah, J.; Lacey, H.; Siddiq, A.; Jain, N. (2024). Emerging Therapeutic Modalities and Pharmacotherapies in Neuropathic Pain Management: A Systematic Review and Meta- Analysis of Parallel Randomized Controlled Trials. Pain Research and Management, 6782574: https://doi.org/10.1155/prm/6782574

Crotty, K.; Gartlehner, G; Viswanathan, M. (2024). Response to Commentary by Mattos et al. (2024). J Consult Clin Psychol, 92, Issue 11: 782-783

Sharifan, A. (2024). Melatonin and erectile dysfunction: addressing research gaps and proposing future investigations. International Journal of Impotence Research, published online: https://doi.org/10.1038/s41443-024-01002-5

GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet, 404: 2278-98

Sharifan, A. (2024). Analysis of Cochrane systematic reviews: A comprehensive study of impact and influence from 1998 to 2024. Cochrane Evidence Synthesis and Methods, 2:12: 1-12

GBD 2021 Tobacco Forecasting Collaborators; Sharifan, A. (2024). Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, Volume 9, Issue 10,: e729 - e744

GBD 2021 Stroke Risk Factor Collaborators; Sharifan, A. (2024). Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, Volume 23, Issue 10: 973 - 1003

Affengruber, L.; Van der Maten, M.M.; Spiero, I.; Nussbaumer-Streit, B.; Mahmic-Kaknjo, M.; Ellen, M.E.; Goossen, K.; Kantorova, L.; Hooft, L.; Riva, N.; Poulentzas, G.; Lalagkas, P.N.; Silva, A.G.; Sassano, M.; Sfetcu, R.; Marqués, M.E.; Friessova, T.; Baladia, E.; Pezzullo, A.M.; Martinez, P.; Gartlehner, G.; Spijker, R. (2024). An exploration of available methods and tools to improve the efficiency of systematic review production: a scoping review. BMC Medical Research Methodology, 24, 210: https://doi.org/10.1186/s12874-024-02320-4

Moser, I.; Sommer, I.; Gartlehner, G. (2024). WHO-Leitlinie zur nicht-operativen Behandlung chronisch unspezifischer Kreuzschmerzen bei Erwachsenen in der Primärversorgung. Das Gesundheitswesen, Online ahead of print.: doi: 10.1055/a-2375-3671.